{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:10:10Z","timestamp":1749183010465,"version":"3.41.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Many medications are associated with phototoxicity or photoallergy, the two types of photosensitivity. Recently, a warning related to increased skin cancer risk was added to the labeling of the popular diuretic hydrochlorothiazide. This article reviews some photosensitizing medications and describes patient education on preventing and recognizing photosensitivity reactions and skin cancer.<\/jats:p>","DOI":"10.1097\/01.jaa.0000931448.63999.de","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T20:00:41Z","timestamp":1685044841000},"page":"8-10","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["What is the relationship between photosensitizing drugs and skin cancer?"],"prefix":"10.1097","volume":"36","author":[{"given":"Emily","family":"Weidman-Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Ferrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"11","key":"R2-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111104","article-title":"Latest evidence regarding the effects of photosensitive drugs on the skin: pathogenetic mechanisms and clinical manifestations","volume":"12","author":"Lozzi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"R3-20250605","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40264-019-00806-5","article-title":"Drug-induced photosensitivity-an update: culprit drugs, prevention and management","volume":"42","author":"Blakely","year":"2019","journal-title":"Drug Saf"},{"issue":"1","key":"R4-20250605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/phpp.12085","article-title":"Photosensitizing medications and photocarcinogenesis","volume":"30","author":"O'Gorman","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.12.003","article-title":"Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis","volume":"122","author":"Gandini","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"R6-20250605","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-10-0652","article-title":"Photosensitizing medication use and risk of skin cancer","volume":"19","author":"Kaae","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/CLEP.S241249","article-title":"Use of antidepressants and risk of cutaneous melanoma: a prospective registry-based case-control study","volume":"12","author":"Berge","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"4","key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tranon.2021.101029","article-title":"Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine","volume":"14","author":"Fritz","year":"2021","journal-title":"Transl Oncol"},{"issue":"7","key":"R9-20250605","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0956462415586316","article-title":"The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis","volume":"27","author":"Zhao","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"3","key":"R10-20250605","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.30443","article-title":"Use of benzodiazepine and risk of cancer: a meta-analysis of observational studies","volume":"140","author":"Kim","year":"2017","journal-title":"Int J Cancer"},{"issue":"18","key":"R11-20250605","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.3889\/oamjms.2019.782","article-title":"Beta blockers and melanoma","volume":"7","author":"Vojvodic","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"issue":"10","key":"R12-20250605","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.31644","article-title":"Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study","volume":"143","author":"Cervenka","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"R13-20250605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1940-6207.CAPR-20-0376","article-title":"Risk of skin cancer associated with metformin use: a meta-analysis of randomized controlled trials and observational studies","volume":"14","author":"Chang","year":"2021","journal-title":"Cancer Prev Res"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2019.104499","article-title":"The association between nonsteroidal anti-inflammatory drugs and skin cancer: different responses in American and European populations","volume":"152","author":"Ma","year":"2020","journal-title":"Pharmacol Res"},{"issue":"8","key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/dom.13745","article-title":"Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: a meta-analysis of randomized controlled trials","volume":"21","author":"Dicembrini","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"R16-20250605","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1111\/dom.13474","article-title":"Meta-analysis of the association between sodium-glucose co-transporter-2 inhibitors and risk of skin cancer among patients with type 2 diabetes","volume":"20","author":"Tang","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"R17-20250605","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bjc.2017.378","article-title":"Tetracycline use and risk of incident skin cancer: a prospective study","volume":"118","author":"Li","year":"2018","journal-title":"Br J Cancer"},{"issue":"2","key":"R18-20250605","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaad.2019.05.055","article-title":"Use of antiepileptic drugs and risk of skin cancer: a nationwide case-control study","volume":"82","author":"Kristensen","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"R19-20250605","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2017.06.032","article-title":"Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation","volume":"77","author":"Kuklinski","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"R20-20250605","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jamadermatol.2020.1141","article-title":"Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States","volume":"156","author":"D'Arcy","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"R21-20250605","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11886-019-1183-z","article-title":"Do thiazide diuretics increase the risk of skin cancer? A critical review of the scientific evidence and updated meta-analysis","volume":"21","author":"Bendinelli","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"R22-20250605","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jaad.2017.11.050","article-title":"Statin use and risk of skin cancer","volume":"78","author":"Lin","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"R23-20250605","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-020-02152-4","article-title":"Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions","volume":"313","author":"Chu","year":"2021","journal-title":"Arch Dermatol Res"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000931448.63999.de","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:02:20Z","timestamp":1749153740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000931448.63999.de"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000931448.63999.de","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}